Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Type of study
Year range
1.
Rev. AMRIGS ; 53(3): 285-290, jul.-set. 2009.
Article in Portuguese | LILACS | ID: lil-566966

ABSTRACT

A qualidade de vida é um desfecho importante quando analisamos os resultados de qualquer tipo de tratamento. No que tange ao diabetes tipo 1, este desfecho torna-se de especial relevância. Os tratamentos mais eficazes para controlar esta enfermidade podem modificar ignificativamente a qualidade de vida dos pacientes. Nos casos de diabetes com complicações crônicas em estágios avançados, o transplante de órgãos passou a ser indicado de forma mais liberal, visando a melhorar a qualidade de vida deste subgrupo de enfermos. Este artigo tem como objetivo revisar as publicações que avaliaram as modificações na qualidade de vida dos pacientes diabéticos tipo 1 submetidos às diferentes modalidades de transplante de órgãos (transplante isolado de rim, transplante simultâneo de pâncreas e rim e transplante isolado de pâncreas).


Quality of life is an important outcome when the results of any type of treatment are analyzed. Concerning diabetes type 1, this outcome becomes especially relevant. The most effective treatments to control this disease may significantly affect the quality of life of the patients. In the cases of diabetes with chronic complications at advanced stages, organ transplantation came to be indicated more frequently, as a measure to improve the quality of life of this subgroup of patients. This article aimed at reviewing the published studies evaluating changes to the quality of life of type 1 diabetic patients following different types of organ transplantation (kidney transplant, simultaneous pancreas-kidney transplant, and pancreas transplant.).


Subject(s)
Humans , Male , Female , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 1/diagnosis , Diabetes Mellitus, Type 1/pathology , Quality of Life/psychology , Pancreas Transplantation/adverse effects , Pancreas Transplantation/methods , Pancreas Transplantation/psychology , Kidney Transplantation/adverse effects , Kidney Transplantation/methods , Kidney Transplantation/psychology , Organ Transplantation
2.
Arq. bras. endocrinol. metab ; 52(2): 355-366, mar. 2008. tab
Article in Portuguese | LILACS | ID: lil-481005

ABSTRACT

O transplante simultâneo de pâncreas/rim tem indicações específicas, riscos e benefícios. O procedimento, cada vez mais realizado, traz vantagens se comparado ao paciente em diálise, em relação à qualidade de vida, anos de vida ganhos e evolução das complicações crônicas. Se o paciente tiver a opção de realizar o transplante de rim com doador vivo, que apresenta sobrevida semelhante do enxerto e do paciente aos dez anos, o procedimento deverá ser considerado. O transplante de pâncreas após rim, quando efetivo, pode melhorar a evolução das complicações cardiovasculares, mas em contrapartida provoca maior mortalidade nos primeiros meses após a cirurgia. O transplante isolado de pâncreas também ocasiona a maior mortalidade pós-operatória, resultado da complexidade do procedimento e da imunossupressão. O transplante de ilhotas tem sua indicação para um seleto grupo de diabéticos com instabilidade glicêmica.


Pancreas and kidney transplants have specific indications, benefits and risks. The procedure has become more common and more often as long-term success has improved and risks have decreased. Compared with a patient being on dialysis, simultaneous pancreas-kidney transplant offers a distinct advantage when it comes to mortality, quality of life and diabetic complications. Since there can be a living-donor kidney transplant,, a possibly similar patient and graft survival by 10 years follow-up, this procedure should be considered. Pancreas after kidney transplants, when successful, can improve microvascular complications compared with kidney transplant alone, but immediate mortality may be higher. Solitary pancreas transplantation can improve the quality of life in selected patients, but it may also increase the immediate risk of mortality due to the complexity of the surgery and the risks of immunosupression. The results of Islet transplantation differ from the higher metabolic performance achieved by whole pancreas allotransplantation and its applicability is limited to selected adult diabetic patients.


Subject(s)
Adult , Humans , Diabetes Mellitus, Type 1/surgery , Islets of Langerhans Transplantation/methods , Kidney Transplantation/methods , Pancreas Transplantation/methods , Chronic Disease , Diabetes Mellitus, Type 1/mortality , Diabetic Angiopathies/etiology , Diabetic Angiopathies/mortality , Diabetic Nephropathies/etiology , Diabetic Nephropathies/mortality , Diabetic Neuropathies/etiology , Diabetic Neuropathies/mortality , Graft Rejection , Immunosuppression Therapy , Islets of Langerhans Transplantation/adverse effects , Islets of Langerhans Transplantation/mortality , Kidney Transplantation/adverse effects , Pancreas Transplantation/adverse effects , Pancreas Transplantation/mortality , Pancreas/blood supply , Survival Rate , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL